NEW YORK, March 27, 2025 /PRNewswire/ -- Cardiologists from NYU Langone Heart are showcasing their latest clinical findings ...

Diabetic wounds often lead to severe complications that can result in amputations. These chronic and non-healing wounds are ...

Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...

Patients with skin disease adhering to a proper diet may experience better treatment responses and a reduced risk of adverse ...

Irene Wells didn't ask just how bad her pancreatic cancer was — she just wanted aggressive treatment so she could do "a ...

The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction ...

Posters presented at the 2025 American Academy of Dermatology Annual Meeting found bimekizumab to have benefits beyond safety ...

In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...